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Erythrocytes have been long considered as “dead” cells with transport of oxygen (O2) as their only function. However, the ability
of red blood cells (RBCs) to modulate the microcirculation is now recognized as an important additional function. This capacity
is regulated by a key element in the rheologic process: the RBC membrane. This membrane is a complex unit with multiple
interactions between the extracellular and intracellular compartments: blood stream, endothelium, and other blood cells on
the one hand, and the intracytoplasmic compartment with possible rapid adaptation of erythrocyte metabolism on the other.
In this paper, we review the alterations in the erythrocyte membrane observed in critically ill patients and the inﬂuence of
these alterations on the microcirculatory abnormalities observed in such patients. An understanding of the mechanisms of RBC
rheologic alterations in sepsis and their eﬀects on blood ﬂow and on oxygen transport may be important to help reduce morbidity
and mortality from severe sepsis.
1.Introduction
The microcirculation, which includes all vessels with a
diameter <100μm, blood cells (red blood cells-RBCs-,
white blood cells-WBCs- and platelets), endothelium, and
microparticles, plays a central role in tissue oxygenation
because it is across the walls of the microvessels that oxygen
(O2)d i ﬀuses from the blood to the cells within each
tissue. Alterations at this circulatory compartment level are
frequently observed in critically ill patients, especially in
those with sepsis [1–5], and persistence of these alterations
is associated with a poor outcome [4, 6].
RBCs were formerly considered as a simple container
(the membrane) for one important cytoplasmic protein:
haemoglobin. The membrane is considered as one of the key
determinants of RBC deformability, alongside cell geometry
and cytoplasmic viscosity. Understanding the relationship
between the diﬀerent components of the membrane (lipids-
50%ofmolecularweight,proteins-40%-andcarbohydrates-
10%-) (Figure 1)[ 6–8] helps explain the deformability
process. All these components may be altered in sepsis,
through a direct eﬀect of bacteria, or via enzymes and/or
reactive oxygen species (ROS) produced by WBCs and/or
platelets. However, few studies have evaluated membrane
alterations during sepsis.
Interestingly, several recent studies have reported an
important role of the RBC in modulating the microcircu-
lation. For these reasons, RBCs are no longer considered
merely as “dead cells” without a nucleus and only a
membrane and haemoglobin to transport O2 and CO2, but
as living cells capable of modulating the microcirculation in
response to various stimuli.
This review ﬁrst reports the alterations in RBC mem-
brane components and biochemistry observed during sepsis
and, second, the possible contribution of these altered RBCs
to the microcirculatory abnormalities observed during sepsis
(Table 1 for summary).
2. The RBC Membrane
The RBC membrane is considered as a key element in
RBC rheology, especially deformability. It is composed of
proteins (52% of the molecular weight), lipids (30%), and
carbohydrates (8%) with complex interactions among these2 Critical Care Research and Practice
Table 1: Main modiﬁcations of the RBC membrane observed during sepsis.
Membrane components Model Modiﬁcations reported Eﬀects References
Proteins
Human RBCs
Membrane glycophorin
A content increased
during sepsis
Desialylation facilitates
glycophorin A ﬁxation [9]
Human serum of
patients with
meningococcemia
No changes in serum
glycophorin A during
the ﬁrst 36hours
[10]
Mice RBCs with sepsis
induced by caecal
ligature and perforation
Increased band
3/α-spectrin ratio
Associated altered RBC
deformability [11]
Phosphorylation of the
band 3 and anion
transporter capacity
No eﬀects on anion
transporter capacity [12]
Human RBCs
Decreased RBC proteins
in septic and non-septic
patients
No diﬀerence between
septic and nonseptic
patients
[13]
Lipids
Human RBCs
Increased membrane
phosphatidylserine
exposition
Increased entry of
calcium → increased
eryptosis ?
[14]
Human RBCs Increased membrane
lipid peroxidation
Modiﬁcations of RBC
lipid organization [15]
Rat RBCs
Controversial results on
membrane lipid
peroxidation
Eﬀects on membrane
ﬂuidity? [16, 17]
Carbohydrates Human RBCs Decreased sialic acid
membrane content
Inverse relationship
between spherical shape
and decreased sialic acid
membrane content.
Stimulation of RBC
glycolysis (increased
lactate,
2,3-diphosphoglycerate)
[9]
elements. The membrane and these interactions have been
reviewed elsewhere [6–8]. Modiﬁcations of RBC membrane
components could alter RBC rheology and probably also
RBCbiochemistry.HerewereviewthealterationsoftheRBC
membrane that have already been described during sepsis.
2.1. Proteins. Few works have studied modiﬁcations of the
protein part of the RBC membrane during sepsis. Nieuwland
et al. [10] measured, in the sera of patients with meningo-
coccaemia, the concentrations of microparticles derived
from leucocytes (granulocytes and monocytes), endothelial
cells, and platelets. As controls, these authors measured
microparticles containing glycophorin A—a major integral
protein of the RBC membrane (Figure 1). These authors
observed increased blood concentrations of the diﬀerent
microparticles from WBCs, platelets, and endothelial cells
during the ﬁrst 36hours of sepsis, but no modiﬁcations in
glycophorin A. These data suggest that the RBC membrane
glycophorin A content remains constant, at least during the
early stage of sepsis [10].
In a mouse model of septic shock induced by caecal
ligation and puncture, Spolarics et al. [11] studied the eﬀects
of sepsis on RBC glucose-6-phosphodehydrogenase (G-6-
PD) knock-out mice. This enzyme, the ﬁrst in the pentose
phosphate pathway, enables the synthesis of NADPH for
glutathione production and antioxidant defenses [8, 18].
These authors observed increased haemolysis in the “knock-
out” mice, with signiﬁcant alterations in RBC deformability.
To explain these results, Spolarics et al. [11] hypothesised
that the RBC membrane becomes unstable because of an
increased band 3/α-spectrin ratio, suggesting an alteration of
the membrane integral/peripheral protein ratio (Figure 1).
Interestingly, this band 3/α-spectrin ratio was also increased
in the group of septic “sham” mice with decreased deforma-
bility but without haemolysis compared to “knock-out”
G6PD mice [11].
T h es a m ea u t h o r s[ 12] continued their studies on sepsis
and the RBC membrane, especially band 3. In the same
animalmodel,theyobservedthatsepsisinducedasigniﬁcant
increased in tyrosine phosphorylation of band 3. This
phosphorylationmodiﬁedthelinkbetweenband3andother
proteins of the membrane, but without eﬀects on the anion
transport capacity of band 3 [12].
Because of interspecies diﬀerences in membrane com-
position, rheology, and biochemistry, these observationsCritical Care Research and Practice 3
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Figure 1: Schematic representation of the red blood cell membrane.
need conﬁrmation in humans. Piagnerelli et al. [13]s t u d -
ied RBC membrane proteins from healthy volunteers and
from patients with and without sepsis within 24hours
of ICU admission, and on day 3 for the septic patients.
Procedures included screening for alterations in RBC mem-
brane proteins using cryohaemolysis and separation of RBC
membrane and skeletal proteins using polyacrylamide gel
electrophoresis in the presence of sodium dodecylsulfate.
The majority of RBC membrane protein ratios, includ-
ing band 3/spectrin, were more elevated in critically ill
patients (nonseptic and septic) than in volunteers, but RBC
membrane skeletal protein content was similar in septic
and nonseptic patients [13]. There were no signiﬁcant
diﬀerences in cryohaemolysis results among groups. The
authors concluded that there were diﬀerences in the RBC
membrane protein content between critically ill patients
within 24hours of ICU admission and healthy volunteers,
but no diﬀerences in membrane protein content in septic
patients compared to non-septic patients, suggesting that
sepsis per se does not alter the RBC membrane protein
content.
ROS can also alter the protein part of the membrane
and thus the deformability. Uyesaka et al. [19]o b s e r v e d
that incubation of RBCs with O2
− induced a rapid and
important degradation of RBC membrane proteins (band 3
and spectrin) with the formation of a new protein band in
the membrane. This new organization of the protein part of
the membrane may decrease RBC deformability [19].
On the other hand, the RBC membrane participates
in ROS synthesis in hypoxic conditions. Kiefmann et al.
[20] recently demonstrated in a rat model of isolated and
perfused lungs that H2O2 w a sp r o d u c e db yR B C sa sa
result of autooxidation of haemoglobin located on the
membrane. RBCs then transported ROS to endothelial cells.
In response, endothelial cells increased intracytosol Ca2+-
inducing P-selectin expression on the plasma membrane
favouring leucocyte adhesion in venules and capillaries. All
these processes contribute to inﬂammation [20].
2.2. Lipids. The lipid portion of the human RBC membrane
may be altered during sepsis. Todd et al. studied, using spec-
troscopy,theeﬀectsofendotoxinsontheviscosityofthelipid
part of the RBC membrane [21]. They noted an increased
viscosity of these lipids without modiﬁcations in mean
corpuscular volume or mean corpuscular haemoglobin
concentration, suggesting no loss of this portion of the RBC
membrane [21] .I n t e r e s t i n g l y ,K e m p ee ta l .[ 14]o b s e r v e d
thatincubationofRBCsfromhealthyvolunteerswithplasma
from septic patients induced phosphatidylserine expression
on the RBC membrane surface suggested by ﬁxation of
annexin V in ﬂow cytometry [14]. These results were
identical when they incubated RBCs with the supernatant4 Critical Care Research and Practice
of bacteria cultures [14]. The physiopathologic mechanism
to explain these results, suggested by Kempe et al. [14], is
the formation of membrane ceramide, which could induce
a signiﬁcant increase in RBC Ca2+ concentrations. This
eﬀe c ti nt u r ns t i m u l a t e sK +-Ca2+ channels, which, with
Cl− channels, drives KCl out of the cells. All of these
modiﬁcationsinducecellulardehydration.Indeed,according
to these authors, sepsis induces eryptosis—programmed
RBC death—in contrast to apoptosis for nuclear cells [22].
Lipid peroxidation of the RBC membrane also seems
to be increased during sepsis. Huet et al. [15]o b s e r v e d
this eﬀect by measuring ROS production, using thiobarbi-
turic acid-malondialdehyde solutions, by RBCs from septic
patients already on the ﬁrst day of severe sepsis. In rats with
sepsis induced by caecal ligature and perforation, Baskurt et
al. also observed signiﬁcantly increased lipid peroxidation
[16], but these results were not conﬁrmed in a study by
Bateman et al. [17].
2.3. Carbohydrates. Carbohydrates are a minor component
of the RBC membrane, representing only 8% of the
molecular weight of the human RBC membrane. The RBC
glycocalyx (Figure 1) is dominated by the carbohydrate
domains of glycolipids and integral glycoproteins. These
oligosaccharides contain, in addition to neutral hexoses,
pentoses and N-acetylhexosamines, fully ionised sialic acid.
Sialic acid (sialon in Greek word: saliva), less commonly
called neuraminic acid, is the designation given to a family
of over 40naturally occurring 9-carbon keto sugars acids
derived from N-acetylneuraminic acid (Neu5AC) [23]. The
most abundant derivative of sialic acid present in humans
and in RBCs is N-acetylneuraminic acid [23]( S A ) .
Glycophorin A, the most important transmembrane
protein, is highly glycosylated, with approximately 60%
of its weight attributable to carbohydrates. Most of the
carbohydrate is in the form of 15O-glycosidically linked
tetrasaccharides. The two SA residues of each of these many
O-glycosidically linked oligosaccharides account for 60% to
90%, depending on the species, of the negative charge of the
RBC membrane surface [24] and account for the fact that
RBCs normally repel each other and do not aggregate [6, 7].
Piagnerelli et al. [9] observed, already within the ﬁrst
24hours of ICU admission, a signiﬁcant inverse relation-
ship between RBC shape, assessed by a ﬂow cytometry
technique, and the RBC membrane SA content in criti-
cally ill patients with and without sepsis. They observed
a more spherical shape in RBCs from septic compared
to non-septic patients and healthy volunteers, associated
with a decreased RBC membrane SA content. To exclude
the possible loss of membrane during the inﬂammatory
process, they measured the ﬁxation of an antiglycophorin
A antibody to the RBC membrane glycophorin A content.
They observed an increased ﬁxation of glycophorin A in
RBCs from septic compared to nonseptic patients and to
healthy volunteers [9]. These results excluded loss of the
membrane and conﬁrmed decreased RBC membrane SA
contentinsepticpatientsfacilitatinglinksbetweenantibody-
glycophorin A. These results were in agreement with the
results of Nieuwland et al. [10]. Interestingly, non-septic
patients also had modiﬁcations of the RBC shape (more
spherical) and decreased membrane SA content compared
to RBCs from healthy volunteers. This group of patients is
an “intermediate” population exhibiting a moderate inﬂam-
matory process that could alter the RBC membrane and
shape. To explain these modiﬁcations of the RBC membrane
SA content, Piagnerelli et al. suggested a possible increased
activity and/or concentration of an enzyme, neuraminidase,
which leaks SA during the inﬂammatory process [9]. Indeed,
these authors also studied the desialylation process on one
circulating protein—transferrin—in critically ill patients
with and without sepsis [25]. In humans, circulating trans-
ferrin is represented by diﬀerent glycoforms. The largest
representative is tetrasialotransferrin, which binds 4SA; the
smallest representative is disialotransferrin, 2SA, accounting
for less than 1% of the concentration. Transferrin is consid-
ered as a “negative” acute phase protein, the concentrations
of which decreases with the inﬂammatory process [26].
Because of the long half-life, approximately 16days in
humans, modiﬁcations of the SA pattern that were measured
in patients are due to changes in a blood degradation rather
than in synthesis. In patients admitted to the ICU with
and without sepsis, these authors [25] observed increased
concentrations of disialotransferrin in septic (18.3% [1.3–
30.5]) compared to non-septic patients (0.7% [0.5–0.9])
and healthy volunteers (0.9% [0.5–1.1]; P<0.05). They also
measuredincreasedconcentrationsofprotein-boundSAand
free SA concentrations in the septic patients. To prove that
thesemodiﬁcationsinSAmetabolismoccurrapidlyinsepsis,
the time course of the free SA concentrations was also
measured in a model of septic shock induced by ligature and
caecal perforation in sheep. An increased concentration of
free SA was observed after 15hours of sepsis in this animal
model [25].
All these modiﬁcations could be explained by increased
concentration and/or activity of neuraminidase. To demon-
strate this hypothesis, the same group measured the neu-
raminidase activity in critically ill patients with and without
sepsis [27]. They observed signiﬁcantly increased neu-
raminidase activity in septic compared to nonseptic patients
and healthy volunteers. To assess the eﬀects of decreased
RBC membrane SA content on deformability assessed by
ﬂowcytometry,theseauthorsincubatedneuraminidasefrom
Clostridium perfringens at several concentrations (0.125,
0.25, and 0.5U/mL) with RBCs from healthy volunteers and
measured the free SA concentrations in the supernatant.
After 2hours of incubation with the higher concentrations
of neuraminidase, these investigators observed the same
modiﬁcations in RBC shape as had been observed in septic
patients [9, 27]. Moreover, the RBC membrane contains a
neuraminidase linked by a phosphatidylinositol link [28].
Incubation of RBCs from healthy volunteers with phos-
phatidylinositol phospholipase C (PIPLC) reproduced the
same alterations in RBC shape and increased SA concentra-
tions as observed in septic patients [27]. These data suggest a
possible liberation of RBC membrane neuraminidase during
sepsis. Nevertheless, several sources of neuraminidase have
been reported: RBC membrane as described above and in
other studies [29–31], WBCs [32–34], platelets [35], bacteriaCritical Care Research and Practice 5
[36–39], and viruses [40, 41]. Indeed, some studies have
shown that RBCs are able to recycle the free SA released by
neuraminidase [42, 43] through a cytosolic sialate pyruvate
lyase that speciﬁcally and reversibly catalyses the cleavage of
SA to form N-acetylmannosamine and pyruvate [42, 43].
3. Links between RBC Alterations and
the Microcirculation
Although several studies performed in animal models of
sepsis and in human sepsis have reported alterations in RBC
rheology [44–56], no studies have demonstrated the eﬀects
of altered RBCs on the microcirculation during sepsis. Sev-
eralstudieshavereportedthedeleteriouseﬀectsoftransfused
altered RBCs in sham animals. In sedated rats, Simchon et
al. [57] showed the eﬀects of transfused RBCs altered by
incubation with glutaraldehyde and neuraminidase. These
authors analysed the clearance of altered RBCs ﬁxed by
Cr51 and In111. They observed a decrease, by approximately
70%, of the altered RBCs in a few minutes in areas (liver,
spleen, lungs, and kidneys) where the reticuloendothelial
system was the most represented. Moreover, the blood ﬂow
neuraminidase RBC/control RBC ratio, measured by the
microsphera technique (15μm, with a value of 1 as normal
range), was markedly decreased for the spleen (0.4±0.05),
for the liver (0.66 ± 0.06), for the lungs (0.78 ± 0.03), and
forthekidneys(0.78±0.09).Thesedatasuggestadeleterious
eﬀect of neuraminidase-altered RBC deformability on blood
ﬂow [57].
Lux et al. [58] studied the eﬀects of RBCs with deforma-
bility altered by diﬀerent concentrations of glutaraldehyde
on the rat pulmonary circulation. These authors observed
an increased pulmonary arterial pressure related to the
severity of the RBC deformability alterations. Baskurt in a
rat model of isolated perfused leg demonstrated the same
eﬀect of altered RBCs on vascular resistance. They measured
an increase in the resistance of up to 78% with the more
altered RBC suspensions [59]. Cabrales [60] compared, in
a model of isovolaemic haemodilution in the hamster, the
eﬀects of RBCs altered by glutaraldehyde, compared with
Dextran 6% 70-kDA, and “fresh” RBCs, on the cutaneous
microcirculation observed by the “window chamber.” He
observed a decrease in ﬂow and in diameter, especially in
the arteriolar part of the microcirculation, with transfusion
of altered compared to fresh RBCs, without modiﬁcations
in blood viscosity. Interestingly, microvascular density was
signiﬁcantly decreased in the rats transfused with altered
RBCswithdecreasedarteriolar,tissues,andvenularPO2[60].
There are several possible hypotheses to explain the
eﬀects of altered RBCs on tissue oxygenation. First, low ﬂow
rates lead to the depletion of arteriolar O2 and lowering
of arteriolar blood PO2. The same eﬀect was observed in
the venular part of the circulation as a consequence of
the lowered ﬂow velocity after exchange with rigid RBCs
leading to low PO2. Thus, the residence time of the RBCs
within the vessel critically inﬂuences the amount of O2 that
diﬀuses into the surrounding tissue, aﬀecting O2 delivery
to the capillary network. The altered RBC is associated in
part with increased surface area-to-volume ratio, supporting
the concept of decreased O2 uploading by rigid RBCs in
the lung. This eﬀect, in combination with the associated
reduced arteriolar ﬂow and functional capillary density,
should explain why tissue and venular PO2 values are signiﬁ-
cantlyreduced.Finally,decreasedfunctionalcapillarydensity
could be explained by microvascular vasoconstriction due to
decreased ATP released by altered RBCs. Nevertheless, these
hypothesesremainspeculative,especiallyinsepticconditions
where decreased ATP release by altered RBCs has never been
studied.
The studies discussed above suggest deleterious eﬀects of
altered RBCs on the microcirculation, but the mechanisms
have not really been evaluated. Moreover, these studies were
not performed in septic models.
4. Relationship between Alterationsin RBC
Rheology, Microcirculation,and Outcome
Few investigations have studied RBC rheology and the
microcirculation in septic patients. Donadello et al. [61]
showed in 64septic patients that worsened RBC deforma-
bility at day 3, as assessed by the laser-assisted optical
rotational cell analyzer (LORCA, Mechatronics Instruments
BV, AN Zwaag, Netherlands), was associated with a poor
outcome. In contrast, RBC aggregation did not change over
time in these patients [61]. Further studies investigating the
microcirculation and RBC rheology in the same patients and
the relationship of these aspects with mortality are needed in
the future.
In conclusion, components of the RBC membrane are
modiﬁed during sepsis and may contribute to the observed
alterations in RBC rheology. A better understanding of these
processes could help identify strategies to improve RBC
rheology and, thus, the microcirculation in this particular
population of patients.
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